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Abstract 
Background: For the majority of the older patients in dialysis, the treatment will be lifelong. 
Thus, quality of life (QoL) is a crucial outcome. Our aim was to assess the QoL of older 
Norwegian dialysis patients and to investigate the impact of early (estimated glomerular 
fraction rate, eGFR ≥ 10ml/min) versus late (eGFR < 10ml/min) start in dialysis, comorbidity, 
nutritional status and physical capacity. 
Methods: A self-report questionnaire including SF-36 (QoL) and the Subjective Global 
Assessment (SGA) (nutritional status) was mailed to all patients (n = 320) > 75 years 
registered in the Norwegian Renal Registry (NRR) as being in dialysis by September 2009. 
Reply was received from 233 patients (73%). Medical data including comorbidities and eGFR 
at dialysis start (obtained for 194 patients) was retrieved from the NRR. Functional capacity 
was determined from the SGA. 
Results:  Compared to reports from younger dialysis patients, our patients scored poorer on all 
SF-36 subscales. Early start in dialysis was registered for 52 patients, 142 patients started late, 
51.4% were well nourished (SGA A), 32.3% moderately malnourished (SGA B) and 16.4% 
were severely malnourished (SGA C).  No significant association between any SF-36 scores 
and early vs. late start, nutritional status or comorbidity was found. Better physical function 
was significantly associated with better scores on all SF-36 scales.  
Conclusions: Our results indicate that physical function is important to all QoL aspects. 
Increased focus on physical rehabilitation seems pertinent. Early start of dialysis treatment 
was not associated with better long term QoL scores. 
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Introduction 
For several reasons, the oldest patients are the fastest growing subgroup of the dialysis 
population in developed countries. The general population is aging and the survival of 
diseases associated with kidney failure improves1,2.  Hence, the incidence of end stage renal 
disease (ESRD) in older adults is increasing 3,  and also the acceptance of older patients onto 
dialysis 4. The majority of the older patients will not be offered a renal transplant and will be 
subjects to lifelong dialysis. In general, Qol of dialysis patients seems to be substantially 
affected, especially the physical domains, which also declines over time5-8. Comparing groups 
of older and younger in dialysis, no difference has been found for the QoL mental domains. 
Results regarding physical domains are more diverse; superiority of scores from the older 
population as well as equality has been reported9,10. For the oldest dialysis patients (> 75 
years), however, the physical scores seem to be poorer than for younger ones7,11. 
Over the last decades, there has been a trend in USA and Europe to start dialysis early, in 
particular among the oldest patients (age > 75 years)12,13  European and American guidelines 
have recommended start in dialysis at estimated glomerular fraction rate, eGFR at 8 – 10 ml 
/min/1.73 m2 14,15.  Early start is in most studies defined as eGFR > 10 ml/min. Some studies 
indicate that early start is connected with a higher mortality 13,16, which may be explained by a 
larger proportion  of older patients17. The only published randomised trial comparing early to 
late start of dialysis, the IDEAL study, found that neither survival nor quality of life improved 
by an early start18. To our knowledge no studies have addressed the impact of early start on 
QoL in older dialysis patients in particular. 
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Older age is associated with higher frequency of health related problems such as nutritional 
deficits, comorbidity and reduction in physical capacity. This may be  attenuated in older 
ESRD patients 19-22 23.  
 In general, nutritional deficits and protein energy wasting (PEW) are frequent problems in the 
dialysis population24-26, and implies an increased risk of negative health outcomes such as 
mortality risk and QoL deterioration27,28. Comorbid disorders are common among dialysis 
patients > 75 years  21, and for  haemodialysis patients in general, co-morbidity is found to be 
associated with mortality as well as QoL 29,30. 
Decline in physical function is a feature of normal aging. Among older dialysis patients, a 
high prevalence of functional disability has been revealed 22. Physical impairments are likely 
to affect QoL negatively, as has also been shown for younger hemodialysis patients31,32. There 
are few studies addressing these issues in the older dialysis patients, thus, the impact on QoL 
is poorly documented. 
The aim of the present study was to assess the QoL of the Norwegian dialysis population aged 
75 years or more, and to explore the impact on QoL of nutritional status, physical function, 
comorbidity and early vs. late start in dialysis.   
 
Subjects and Methods 
All patients ≥ 75 years (n=320) who, according to the Norwegian Renal Registry (NRR) were 
in dialysis by January 2009 and alive by September 2009 were asked to participate and mailed 
the study questionnaire (September 2009). A reminder was sent 2 weeks later. We received 
answers from 233 (73%). 
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Medical data were collected from the NRR and included data registered at start of dialysis 
treatment and in the Annual Report 2008. The NRR consists of data from all the dialysis 
centres in Norway. These centres are responsible for reporting data from patients with chronic 
kidney failure at start of dialysis and thereafter annually. Deadline for the completion of the 
annual data is by the end of March, thus The Annual Report 2008 includes data on 
biochemical parameters, blood pressure, medications, physical status, and new co-morbid 
diseases up to March 2009.  
The questionnaire mailed to the patients in this study, included assessments of QoL and 
nutrition. QoL was measured with a Norwegian validated translation of the Medical 
Outcomes Study 36 item Short Form health survey (MOS SF-36)33,34. The SF-36 is a self-
administered questionnaire that is widely used and validated in chronic dialysis patients of all 
ages9,11,35-37.  The 36 items are summarised into 8 scales, physical function (PF), role physical 
function (RP), bodily pain (BP), general health (GH), vitality (VT), social function (SF), role 
emotional function (RE) and mental health (MH). For each scale the scores are  transformed 
to scores  ranging from 0 -100 ( 100= best possible health state)  38. The patients’ scores in 
this study were compared to normative data from the general Norwegian population of the 
same age and gender  33 and to younger Norwegian dialysis patients (mean age 59.6 years 
with mean dialysis vintage 16.8 months) 39. 
We also used three items from The European Organisation for Research and Treatment of 
Cancer (EORTC QLQ-C30), i.e. the nausea-vomiting scale (2 items) and the appetite scale (1 
item). These items are scored on a four point categorical scale ranging from “not at all” to 
“very much” transformed into 0-100 scales where the higher scores represent more symptoms 
40.  The patients’ score were compared to the general Norwegian population of the same age 
and gender41. 
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Nutritional status was assessed by the Subjective Global Assessment of Nutritional status 
SGA 42, using a translated Norwegian version 43.  The SGA has two parts. The first includes 
questions on medical history (present weight, weight loss during the last 6 months, changes in 
food intake, gastrointestinal symptoms and physical capacity) and may be answered by the 
patients. The second part covering assessment of subcutaneous fat loss, muscle wasting and 
oedemas, should be filled in by health professionals. In this study, the questionnaires were 
mailed to the patient hence; the nutritional classification was therefore only based on medical 
history. Patients with a body mass index (BMI) > 24 who reported, stable weight or weight 
gain the past two weeks were classified as SGA A (well nourished). This classification was 
also used for patients with weight loss, < 5% but no gastrointestinal symptoms. Patients with 
BMI > 24 with weight loss 5-10%,  were classified as SGA – B (moderately malnourished); 
while patients with BMI < 24 or BMI > 24 and weight loss > 10% were classified as SGA – C 
(severely malnourished)44.  The classification was independently made by two trained 
reviewers, a nephrologist and a nutritionist respectively. In case of disagreement, the 
classification was discussed to reach consensus. 
The patients’ body mass index (BMI) was calculated according to standard formula (body 
weight (kg)/ height (m) ²). The patients’ height was retrieved from the NRR data.  Information 
about the patients’ weight was available from the NRR at start of dialysis and the Annual 
Report 2008 as well as from the SGA (September 2009). BMI was calculated for the 
corresponding three points in time. To estimate weight changes (delta weight), we used 
weight at start of dialysis minus weight from the Annual Report.  
To assess co-morbidity, we used medical data from the NRR, which records 6 possible co-
morbid diseases at start of dialysis; left ventricular hypertrophy (LVH), coronary disease, 
peripheral vascular disease, cerebrovascular disease, diabetes mellitus type II and malignancy. 
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We divided the patients into 3 groups; 1) no comorbid disease, 2) 1-2 co-morbid diseases, and 
3) ≥ 3 co-morbid diseases. 
To determine physical function we used the scores from the SGA item where the patients are 
asked to rate their functional capacity into 4 categories (normal activity, able to be up, mostly 
sitting in a chair or mostly in bed), as well as the physical function scale from the SF-36. 
We defined early start in dialysis at eGFR ≥ 10 ml/min and late start at eGFR< 10 ml/min. 
 
Statistical analysis 
 
Medical and demographic parameters and QoL scores were compared between groups defined 
according to gender, dialysis modality and early versus late start in dialysis. For the medical 
and demographic data, Students’t-test was used to test for statistical significance. For the 
quality of life (SF-36) scores, which were not normally distributed, we used the Mann-
Whitney U test. To ease the interpretation and the comparison to findings of other studies, the 
SF- 36 (QoL) scores are, however, presented in terms of group means.   
Furthermore, the association between SF-36 scores and the following variables: early versus 
late start in dialysis, comorbidity, nutritional status (SGA classification) and physical capacity 
(SGA score and SF-36 physical functioning score) was tested by both  the Kruska Wallis and 
the Wilcox rank sum tests.  We also tested for trends in differences of SF-36 scores between 
groups defined according to comorbidity, SGA classification (A, B, C) and physical capacity 
using the Jonckheere (Kendall Tau) test. 
The SPSS version 18 was used for descriptive statistic and the simple group comparisons, 
whereas the Stata version 12.0 was used for the tests of association and trends. Statistical 
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significance was defined as p< 0.05, and clinical significance for the difference between QoL 
scores was defined as a difference of 10 or more 45. 
The study was approved by The Regional Committee for Research Ethics in Norway 
 
Results 
Demographics 
A total of 233 dialysis patients were included, 67% men and 33% women (Table 1). For four 
of the patients dialysis modality was not registered (three men and one woman).  
Insert Table I 
Overall, 182 (79%) of the patients were followed by a nephrologist for more than four months 
prior to dialysis initiation (early referral). Early start of dialysis (eGFR≥ 10 ml/min) was 
registered for 52 (23%) of the patients, 142 (62%) had a late start, whereas for 39 patients, the 
eGFR at start of dialysis was not recorded in the NRR (Table 1). Mean age at start of dialysis 
was 78.4 years (± 4.1), median age 78.0 years. There was no statistical significant difference 
in age between early and late starters (p= 0.52). The proportions of early and late start did not 
differ between genders or dialysis modality. And no significant statistical difference was 
observed in treatment months between early and late starters (p=0.13). 
Co-morbidities at start of dialysis according to the NRR is shown in Table 1, 48 patients 
(21%) had no comorbidity, 128 (55%) had 1-2 comorbid diseases and 55 (24 %) had ≥ 3 co-
morbidities. Data was missing for 2 patients.  There were more diabetes mellitus in early 
starters both as primary kidney disease (17% vs. 6%) and as comorbid disease (38% vs. 20%) 
(Table 1). 
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The mean age of the patients registered in Annual report 2008 was 80.4 years, median 80.0 
years; range (75 – 94 years) (Table 2). There was no age difference between genders or 
between groups according to dialysis modality (Table 2).   
Insert Table 2,  
 HD patients had significant longer dialysis vintage than PD patients. Otherwise, no difference 
between genders, HD and PD patients or early vs. late start in dialysis was revealed. The use 
of both erythropoiesis stimulating agents (ESA) and statins increased from start of dialysis to 
the Annual Report 2008 (Table 1 and 2). 
 
Nutritional status 
Information about height was missing for 39 patients at start of dialysis treatment, only 4 
missing at Annual report 2008. Mean BMI at start of dialysis, by the time of the Annual report 
2008 and based on the SGA data (September 2009) was 25.1 (median 24.4, range 15.4- 44.3) 
(Table 1), 24.3 (median 23.9, range 13.5-41.3) (Table 2) and 24.3 (median 24.0, range 15.2-
43.5) respectively. Although the BMI showed only minor changes from start of dialysis to the 
Annual Report 2008, a majority of the patients who had data available on both time points (n 
= 185) had experienced weight changes, equally with weight loss (49%) and weight gain 
(42%) (Table 3).  
                                 Insert Table 3 
Completion of the SGA was missing for 13 patients; hence SGA status (A, B or C) could be 
determined for 220 patients (Table 3). SGA status A was present in 51.4 %, SGA B in 32.3% 
and 16.4 % were severely malnourished (SGA C). 
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There were no association between SGA status and eGFR at start of dialysis, serum 
cholesterol, treatment months, serum albumin and haemoglobin (Table 3).  
Scores for EORTC QLQ-C30 items were available for 214 (92 %) of the patients. Nausea-
vomiting scores were clinically significant higher for our patients compared to norm data41, 
both for men and women, indicating more symptoms in our patients.  
 
Quality of life outcomes 
The SF-36 scores for the overall study population as well as scores according to gender, 
dialysis modality and early versus late start in dialysis are presented in Table 4.  
Insert Table 4 
There were 226 patients who completed the SF-36 form. Missing data for the various SF-36 
subscales was observed for 7 patients (SF) to 20 patients (RE).  
Compared to a Norwegian norm reference population of same age and gender 33,  we found 
that both females and males reported clinically significant lower scores on  SF-36 scales. 
These differences in scores were generally high, reaching 40 point for vitality (VT) (data not 
shown).  
Compared to scores from a younger cohort of Norwegian dialysis patients, the women in our 
study reported clinically significant poorer physical function (PF), role physical function (RP) 
and role emotional function (RE), whereas our male patients reported clinically significant 
poorer scores for PF only (Table 4). 
Except for statistically significant higher scores for social function among women compared 
to men, we found no clinically or statistically significant difference in QoL scores between 
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genders, patients starting early or late in dialysis, or between HD and PD patients (Table 4).  
Furthermore, comparing SF-36 scores between patients in the three comorbidity groups as 
defined, no clinically or statistically significant difference was found (data not shown). 
Overall, there were also only minor variations between the SF-36 scores of patients classified 
as SGA A, B and C (data not shown), and no statistically significant trend between SGA 
groups was observed.  
Finally we compared the SF-36 scores between patients according to their own physical 
capacity ratings in the SGA questionnaire and found a clear statistically significant trend, i.e. 
the highest score for physical capacity corresponded to the highest score for SF-36, except for 
RE (Table 5). 
Insert table 5 
We found no linearity between any SF36 domains and treatment months (linear 
regression analysis and scatter-plots). We did regression analysis, and found no 
association between comorbidity, early vs. late start or nutritional status and SF 36 
scores. These results are not reported because the SF36 scores in our study were not 
normally distributed. 
 
Discussion 
In this cross-sectional study addressing Norwegian dialysis patients > 75 years of age, we 
found that quality of life as assessed by the SF-36 in general was poor. For all dimensions, the 
scores were substantially lower than scores from a norm population beyond 70 years of age 33,  
and most scores were also lower compared to younger Norwegian  dialysis patients  39, in 
particular for physical domains. No significant association between the QoL scores and 
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comorbidity, early vs. late start in dialysis and nutritional status was found. All QoL domains 
were, however, clearly associated to the patients’ physical function.  
Few studies have hitherto addressed the impact of physical function on quality of life in older 
dialysis patients 32. In younger dialysis patients, however, significant improvement of physical 
QoL domains as a result of training has been documented  31 46.  Similar results have been 
reported from a Cochrane review of training studies in elderly 47. Our results indicate that 
physical function is highly important, not only to the physical, but also the mental QoL 
domains of older dialysis patients. Thus, maintaining these patients` independence and 
physical performance seems crucial to their overall wellbeing. An existing potential for 
rehabilitation through physical exercise, even for seriously ill patients, is documented among 
advanced cancer patients 48 as well as in a pilot trial of  older haemodialysis patients 49. 
Further studies on training interventions in older dialysis patients are advocated. 
No difference in quality of life between early or late start in dialysis were observed in our 
study, the same conclusion was drawn from the IDEAL-study18. We found in our study 
population that there was no difference in age at start of dialysis or dialysis vintage between 
early and late starters. Our results, however, must be interpreted with caution due to a low 
number of patients starting early and a  lower mean eGFR at start  than reported from others, 
i.e. in 2010, mean eGFR at start for patients > 75 years in US was 12.2 ml/min, while in our 
study population the mean eGFR at start was 8.6 ml/min 4. Furthermore we did not have any 
QoL registration at start of dialysis nor any longitudinal assessments. In a previous study early 
starters were found to have better QoL than late starters immediately after the initiation of 
dialysis treatment, but the difference disappeared after 12 months6. We cannot rule out that 
this would also be the case among our patients.                                                                                                                                             
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Opposed to studies on younger dialysis patients showing a positive correlation between 
nutritional status and SF36 physical composite score (PCS)50,51, we found no significant 
association between QoL and SGA classification, unintentional weight changes or BMI. 
These findings should be interpreted with caution since the SGA classification depended only 
on patients` report without any clinical investigations. However, abridged version of SGA is 
used in other studies and has demonstrated sensitivity and specificity comparable to the full-
length questionnaire52-55. A study on patients on hemodialysis indicated  even that using only 
the nutrition impact symptoms score from the scored version of the questionnaire (patient-
generated SGA (PG-SGA)) had discriminatory capacity comparable to that of a full PG-SGA 
score for identifying malnutrition risk in malnourished patients receiving hemodialysis56.   
BMI reflects weight, and both weight and weight changes can be a difficult parameter in 
dialysis patients because of the ultrafiltration and difficulties in estimating dry weight. 
However, many of our older dialysis patients had a low BMI, reduced food intake and 
unintentional weight loss, indicating that focus on nutritional status is highly important. We 
also found a high frequency of nutritional deficits in a small study on older dialysis patients (≥ 
75 years) where bio-impedance spectroscopy, SGA and anthropometry were used as 
assessment tools57. To identify nutritional risks, we find that adding methods other than 
weight and BMI are necessary. 
For younger dialysis patients, an association between comorbid conditions and QoL, specially 
for physical composite score (PCS) has been shown 30. This finding was not confirmed in our 
study population. A limitation of the co-morbidity registration in our study is the lack of 
information about the severity of the disease. Our registration is based on counting comorbid 
diseases, the same as in comorbidity indexes like Davies58,59.  Many conditions that are 
important for elderly were not registered, e.g. cognitive function, vision and hearing 
disability, chronic obstructive lung disease and depression. Thus, we cannot rule out that the 
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results would have been different with more a complete registration of co-morbid diseases. 
The frequency of comorbid disorders in our study, is, however comparable to registrations 
from the UK and France 21,60, and in the Broadening Options for Long-term Dialysis in the 
Elderly (BOLDE) study from UK,  increasing co-morbidity was found to have a  negative 
impact on QoL only  when malnutrition was present 61.  
The study was based on self-report and register data from NRR, and we had only access to 
NRR data from the patients who accepted to enter the study. Thus, a limitation of the study is 
the lack of information regarding the non-responders. However, the NRR includes all 
Norwegian patients starting in dialysis, there were few missing data compared to other renal 
registries21,62, and we had a high response rate (73%). Overall, we find that our findings may 
be representative for older dialysis patients in general. We also find that more complete data 
on comorbidity as well as inclusion of longitudinal quality of life assessments could 
considerably improve the utility of this and comparable registries. 
Our results confirm that the QoL of older dialysis patients is poor and that there is a room for 
improvement. As low physical capacity seems to have a profound impact on all QoL 
dimensions, increased focus on physical rehabilitation seems pertinent. In accordance with 
results from other trials, our findings indicate that the patient’s long term QoL does not 
benefit from an early start of dialysis.  Nutritional problems were frequent among our older 
patients. By the methods used in this study, we could not confirm any association between 
nutritional status and QoL. Increased focus on nutritional status seems, however, still 
necessary 
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Table 1. Patients’ characteristic at start of dialysis treatment  
 
 All (n = 233) Early start (n=52) Late start (n=142) 
 Mean (SD) n Mean  (SD) n Mean (SD) n 
Age years 78.4 (4.2)  79.4 (3.7)  79.1 (3.4)  
eGFR at start, (MDRD), ml/min 8.63  (3.32) 194 12.82 (3.09) 52 7.09 (1.66) 142 
Albumin    37.5 (3.9)  37.7 (4.5)  
Body mass index (BMI)kg/m² 25.1   (4.6) 194 2.1 (5.5)  24.5  (3.6)  
Hemoglobin g/L 11.1  (1,5) 194 10.9 (1.2)  11.1 (1.6)  
    
 n  (%) n  (%) n  (%) 
Male 
Female 
126 
57 
 34 
8 
 
(69)  
(31) 
92 
49 
(65) 
(35) 
Dialysis modality       
 Hemodialysis (HD) 188  (82) 43 (84) 108 (78) 
 Peritoneal dialysis (PD) 41 (18) 8 (16) 31 (22) 
Access HD       
 Catheter   99 (43) 26 (50) 73 (51) 
 AV fistula             
Unknown                                                                                               
53 (23) 15 
11 
(29) 
(21) 
38 
31 
     (27) 
(22) 
        
Use of       
 Erythropoiesis stimulating 
agents (ESA)  
156 (67) 35 (67) 96 (68) 
 Statins  132 (56) 32 (62)                  81 (57) 
Primary kidney disease       
 Glomerulonephritis 37 (16) 9 (17) 32 (23) 
 Pyelonephritis 15 (6) 3 (6) 10 (7) 
 Polycystic kidney disease 15 (6) 2 (4) 10 (7) 
 Renovascular disease 108 (47) 26 (50) 67 (47) 
 Diabetes mellitus 19   (8) 9 (17) 8 (6) 
 Others 40   (17) 3 (6) 15 (11) 
Co-morbidity       
 Left ventricular hypertrophy 60  (26) 15 (29) 55 (39) 
 Peripheral vascular disease 51  (22) 14 (27) 28 (20) 
 Cerebrovascular disease 41  (18) 13 (25) 18 (13) 
 Malignancy 46  (20) 8 (15) 35 (25) 
 Coronary disease 107 (46) 27 (52) 64 (45) 
 Diabetes mellitus II 56  (24) 20 (38) 29 (20) 
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Table 2.  Patients’ characteristics at the Annual report 2008 
 
  All 
(n=233) 
Early start 
(n= 52) 
Late start 
(n= 142) 
 
 
p-value1 
Hemodialysis 
(HD) 
(n=188) 
Peritoneal 
dialysis (PD) 
(n=41) 
 
 
p-value2 
 n Mean  SD Mean  (SD) Mean  (SD)  Mean (SD) Mean (SD)  
Hemoglobin g/L 230 11.6  (1,2) 11.8 (1.1) 11.5 (1.3) 0.23 11.5 (1.2) 11.7 (1.1) 0.28 
Blood pressure, systolic 230 141  (22) 141 (22) 142 (23)     0.76 141 (22) 141 (18) 0.95 
Blood pressure, diastolic 230 72  (12) 71 (13) 72 (12) 0.65 72 (13) 70 (9) 0.36 
Cholesterol  226 4.3  (1.3) 4.2 (1.3) 4.4 (1.3) 0.64 4.3 (1.3) 4.2 (1.1) 0.53 
Albumin g/L 229 37.8  (4.4) 37.5 (3.9) 37.7 (4.5) 0.85 37.1 (4.4) 37.4 (4.0)      0.55 
BMI kg/m² 223 24.3  (3.9) 25.1 (4.0) 24,2 (3,8) 0.85 24.3 (4.0) 24.2 (3.4) 0.95 
Treatment months3 230 36.7  (28.7) 24.5 (12.0) 27.7 (13.0)     0.13 38.9 (30.8) 27.2 (15,2)    0.019* 
Dialyses per week (HD) 188 2.7  (0.5) 2.6 (0.6) 2.7 (0.5)     0.17    
Use of         
 ESA; n (%)  206 (88) 44  (85)  126 (89)  169 (90) 36 (88)  
 Statins; n (%)  143 (61) 36  (69)   80  (56)  112 (60) 30 (73)  
1 Comparisons between early and late starters (Students’ t-test) 
2Comparisons between HD and PD patients (Students’ t-test) 
3 from start in dialysis to 01.09.2009 
* Statistically significant differences,  
Comparing means between early vs. late starters and dialysis modality- t test 
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Table 3. Nutritional parameters according to SGA classification 
 
 All  
(n=220) 
SGA A 
(n=113) 
SGA B 
(n= 71) 
SGA C 
(n=36) 
P values 
 mean (SD) mean (SD) mean (SD) mean (SD  
Se albumin g/L   38.3 (4.0) 37.2 (4.6) 37.3 (4.9) 0.59 
Se cholesterol 2008   4.3   (1.2) 4,2 (1,2) 4,6 (1,6) 0.70 
eGFR at start (ml/min)   8.5 (2.9) 8.8  (4.2) 8.5 (2.9) 0.84 
Hemoglobin 2008 g/L   11.5 (1.2) 11.7 (1.2) 11.4 (1.3) 0.47 
Treatment months   37.7 (31.2) 33.1 (24.2) 39.9 (30.5) 0.62 
BMI kg/m² at start of dialysis   24.8 (3.8) 25.8 (4.9) 23.0 (2.7) 0.13 
BMI kg/m² Annual report 2008   25.6 (3.7) 24.0 (3.4) 20.7 (2.9) 0.000¹ 
          
Appetite loss  (EORTC QLQ-C30) 
n=208 
12.2² (23.0) 13.2 (24.2) 11.1 (20.2) 13.5 (25.2)  
Nausea/vomiting (EORTC QLQ-
C30) n=214 
22.4³ (25.0) 19.0 (22.6) 29.4 (28.5) 24.7 (25.7)  
 n % n % n % n %  
Weight loss  91 (49) 37 (41) 31 (56) 17 (56)  
Weight gain  77 (42) 44 (48) 19 (35) 11 (37)  
¹ statistical significant p < 0.05  
² Scores from norm population: Appetite loss: male: 8.6, female: 15.3 
³Scores from norm population: Nausea/vomiting scale: male: 3.3, female: 8.4 
 
 
 
 
 
 
 22 
Table 4. Quality of life scores (SF 36) according to gender, dialysis modality and start in dialysis. 
  
All 
(n = 226) 
 
Male 
(n = 149) 
 
Female 
(n = 76) 
  
HD 
(n=167) 
 
PD 
(n=33) 
  
Early start 
(n= 45) 
 
Late start 
(n= 124) 
 Norwegian dialysis pts. 
Male 
(n= 199) 
Female 
(n = 102) 
 Mean (SD) Mean (SD) Mean (SD) p-value1 Mean Mean p-value2 Mean Mean p-value3 Mean Mean 
PF 40.9   (27.4)  40.5* (27.4) 39.9* (26.7) 0.93 41.5 37.8  0.62 39.9     40.2    0.80 56.7  49.9  
RP 17.9   (32.8)   19.3 (34.2) 17.0* (31.8) 0.65 19.3 11.1  0.07 16.7      15.4    0.95 24.0  26.5  
BP 57.3   30.  (30.2) 55.5  (29.4)     58.0  (31.7) 0.69 56.8  61.8  0.31 56.9      55.7    0.83 60.1  52.7  
GH 45.7   (23.3) 44.8 (21.4) 48.5  (25.7) 0.40 46.3  44.2 0.74 50.0      44.7   0.12 44.0  41.7  
VT 39.3   (22.2) 38.5 (21.0) 39.1  (22.2) 0.77 40.1  33.3  0.33 38.2       38.7    0.83 44.4 42.9  
SF 63.0  (29.2) 60.1 (28.6) 68.0  (29.2) 0.04 61.5  70.5 0.10 58.7       63.5 0.30 66.2 65.6  
RE 42.7  (43.7) 47.4  (44.5)     38.6* (42.0) 0.22 43.8      40.7  0.62 41.7       45.3  0.76 52.6 57.1  
MH 73.6 (20.2) 72.2  (20.3) 73.3 (17.6) 0.39 73.9  72.3  0.62 73.2 73.3     0.82 75.5 72.6  
 
 
All 
(n = 226) 
 
Male 
(n = 149) 
 
Female 
(n = 76) 
  
HD 
(n=167) 
 
PD 
(n=33) 
  
Early 
start 
(n= 
45) 
 
Late 
start 
(n= 
124) 
 Norwegian 
dialysis pts. 
Male 
(n= 
199) 
Female 
(n = 
102) 
 63.0  (29.2) 60.1 (28.6) 68.0  (29.2) 0.04 61.5  70.5 0.10 58.7       63.5 0.30 66.2 65.6  
PF = physical function, RP = role physical function, BP = bodily pain, GH = General health, VT = vitality, SF = social function, RE = role 
emotional function, MH = mental health;  
1 Comparison between genders (Mann Whitney U test) 
2  Comparison between HD and PD (Mann Whitney U test) 
3  Comparison between patients starting early and late in dialysis (Mann Whitney U test) 
* A difference in scores of 10 points or more between the study populations and scores reported from a younger Norwegian dialysis population (a clinically 
significant difference)  
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Table 5.  SF- 36 scores according to physical capacity as rated in the SGA questionnaire 
 
SF 36 
scores 
Normal 
N= 39 
Some activities 
N= 77 
Mostly in chair 
N= 76 
Mostly in bed 
N= 6 
P values¹ 
 Mean (SD) Mean  (SD) Mean  (SD) Mean (SD)  
PF 47.6   (28.8) 40.0   (26.6) 37.7   (27.6)* 29.3  (32.4)* 0.042 
RP 34.4  (40.1) 17.2  (32.5) 11.9   (28.1)* 0*  0.001 
BP 67.0  (29.6) 57.7  30.0) 52.8  (29.0)* 27.7  (25.7)* 0.003 
GH 51.5  (23.2) 45.8  (24.5) 43.2  (20.8) 29.8  (23.8)* 0.026 
VT 45.5  (24.4) 39.4  (23.3) 35.8  (20.6)* 34.3  (20.7)* 0.040 
SF 71.3  (32.1) 63.6  (27.8) 57.7  (28.2)* 57.1  (38.1)* 0.011 
RE 57.9  (43.6) 36.9  (41.9) 41.8  (44.2)* 22.2  (40.4)* 0.095 
MH 77.1  (21.7) 74.1  (20.9) 72.6  (17.8) 50.0  (20.7)* 0.029 
 
* > 10 points difference in SF 36 scores compared to the group with normal physical capacity 
      ¹ trend analysis (Jonckheere trend test) 
 
 
